Relationship between Serum Level of Prostate-specific antigen and BPH merge prostatitis
Objective To study the serum prostate specific antigen with prostatitis merger benign prostatic hyperplasia patients clinical cases correlation. Methods Choose from April 2010 to January 2012 to the hospital diagnosis have lower urinary tract obstruction symptoms after surgery and pathological diagnosis after treatment for 116 cases of benign prostatic hyperplasia patients as the research object, preoperative through international prostate symptom score result was 21.4±8.4, the quality of life score was 4.0±0.8, urine flow rate 8.2±3.3ml/s, prostate volume 70.3 ±35.5ml residual urine 81.3±105.5ml, serum PSA value<4ng/ml is 51cases(44.0%), 4-10ng/ml is 45 cases(38.8%), more than 10ng/ml is 20 cases(17.2%). Results The level of serum PSA with patient age, prostate symptom scores, the quality of life, the biggest urine flow velocity, residual urine volume no significant correlation with prostate volume has significant positive correlation; Serum PSA levels and prostate volume and the incidence of urinary retention with statistical significance. Hyperplasia of prostate tissue samples to prostatic hyperplasia is given priority to, or associated with infarction venereal disease patients with focal serum prostate specific antigen levels increased significantly. Conclusion More than half accepted surgical treatment of benign prostatic hyperplasia patients serum prostate specific antigen levels, prostate volume increased, urinary retention and performance for prostate hyperplasia is given priority to, or associated with infarcts of prostate hyperplasia is serum prostate specific antigen levels of the main factors.
Benign prostatic hyperplasiaProstate specific antigenProstatitis
NETL
NSTL
万方数据
维普
